# Talzenna

NDC: 0069-0296
Generic name: talazoparib
Labeler / Manufacturer: Pfizer Laboratories Div Pfizer Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20181026
Marketing ended: 20270131
FDA application: NDA211651

## Active ingredients

- TALAZOPARIB TOSYLATE: .25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0069-0296"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0069-0296
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f2423edd-6d24-495c-aec1-c2f457f08d9a